Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Elan seeks acquisitions after $3.25 bn Biogen Idec deal, rival Bayer eyed on MS treatments
Elan seeks acquisitions after $3.25 bn Biogen Idec deal, rival Bayer eyed on MS treatments
Elan seeks acquisitions after $3.25 bn Biogen Idec deal, rival Bayer eyed on MS treatments
Submitted by
admin
on February 7, 2013 - 11:03am
Source:
Financial Express
News Tags:
Elan
Bayer
M&A
Biogen Idec
Tysabri
Headline:
Elan seeks acquisitions after $3.25 bn Biogen Idec deal, rival Bayer eyed on MS treatments
Do Not Allow Advertisers to Use My Personal information
